Generic placeholder image

Current Pharmaceutical Design

Editor-in-Chief

ISSN (Print): 1381-6128
ISSN (Online): 1873-4286

General Review Article

Berberine Exerts Anti-cancer Activity by Modulating Adenosine Monophosphate- Activated Protein Kinase (AMPK) and the Phosphatidylinositol 3-Kinase/ Protein Kinase B (PI3K/AKT) Signaling Pathways

Author(s): Jin Huang, Wei Feng, Shanshan Li, Huiling Tang, Siru Qin, Wei Li, Yinan Gong, Yuxin Fang, Yangyang Liu, Shenjun Wang, Yi Guo, Zhifang Xu* and Qian Shen*

Volume 27 , Issue 4 , 2021

Published on: 28 September, 2020

Page: [565 - 574] Pages: 10

DOI: 10.2174/1381612826666200928155728

Price: $65

Abstract

Background: The antagonistic relationship between adenosine monophosphate-activated protein kinase (AMPK) and phosphatidylinositol 3-kinase/protein kinase B (PI3K/AKT) signaling play a vital role in cancer development. The anti-cancer effects of berberine have been reported as a main component of the traditional Chinese medicine Rhizoma coptidis, although the roles of these signaling pathways in these effects have not been systematically reviewed.

Methods: We searched the PubMed database for studies with keywords including [“berberine”] and [“tumor” or “cancer”] and [“AMPK”] or [“AKT”] published between January 2010 and July 2020, to elucidate the roles of the AMPK and PI3K/AKT pathways and their upstream and downstream targets in the anti-cancer effects of berberine.

Results: The anti-cancer effects of berberine include inhibition of cancer cell proliferation, promotion of apoptosis and autophagy in cancer cells, and prevention of metastasis and angiogenesis. The mechanism of these effects involves multiple cell kinases and signaling pathways, including activation of AMPK and forkhead box transcription factor O3a (FOXO3a), accumulation of reactive oxygen species (ROS), and inhibition of the activity of PI3K/AKT, rapamycin (mTOR) and nuclear factor-κB (NF-κB). Most of these mechanisms converge on regulation of the balance of AMPK and PI3K/AKT signaling by berberine.

Conclusion: This evidence supports the possibility that berberine is a promising anti-cancer natural product, with pharmaceutical potential in inhibiting cancer growth, metastasis and angiogenesis via multiple pathways, particularly by regulating the balance of AMPK and PI3K/AKT signaling. However, systematic preclinical studies are still required to provide scientific evidence for further clinical studies.

Keywords: Berberine, anti-cancer, AMPK, PI3K/AKT, mechanism, rhizoma coptidis.

[1]
Hsu PP, Sabatini DM. Cancer cell metabolism: Warburg and beyond. Cell 2008; 134(5): 703-7.
[http://dx.doi.org/10.1016/j.cell.2008.08.021] [PMID: 18775299]
[2]
Ward PS, Thompson CB. Metabolic reprogramming: a cancer hallmark even warburg did not anticipate. Cancer Cell 2012; 21(3): 297-308.
[http://dx.doi.org/10.1016/j.ccr.2012.02.014] [PMID: 22439925]
[3]
Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144(5): 646-74.
[http://dx.doi.org/10.1016/j.cell.2011.02.013] [PMID: 21376230]
[4]
Carling D. AMPK signalling in health and disease. Curr Opin Cell Biol 2017; 45: 31-7.
[http://dx.doi.org/10.1016/j.ceb.2017.01.005] [PMID: 28232179]
[5]
Faes S, Dormond O. PI3K and AKT: Unfaithful Partners in Cancer. Int J Mol Sci 2015; 16(9): 21138-52.
[http://dx.doi.org/10.3390/ijms160921138] [PMID: 26404259]
[6]
Thorpe LM, Yuzugullu H, Zhao JJ. PI3K in cancer: divergent roles of isoforms, modes of activation and therapeutic targeting. Nat Rev Cancer 2015; 15(1): 7-24.
[http://dx.doi.org/10.1038/nrc3860] [PMID: 25533673]
[7]
Pang B, Yu XT, Zhou Q, et al. Effect of rhizoma coptidis (Huang Lian) on treating diabetes mellitus. Evid Based Complement Alternat Med 2015; 2015: 921416.
[http://dx.doi.org/10.1155/2015/921416] [PMID: 26508987]
[8]
Singh IP, Mahajan S. Berberine and its derivatives: a patent review (2009 - 2012). Expert Opin Ther Pat 2013; 23(2): 215-31.
[9]
Ko WH, Yao XQ, Lau CW, et al. Vasorelaxant and antiproliferative effects of berberine. Eur J Pharmacol 2000; 399(2-3): 187-96.
[http://dx.doi.org/10.1016/S0014-2999(00)00339-3] [PMID: 10884519]
[10]
Sánchez-Chapula J. Increase in action potential duration and inhibition of the delayed rectifier outward current IK by berberine in cat ventricular myocytes. Br J Pharmacol 1996; 117(7): 1427-34.
[http://dx.doi.org/10.1111/j.1476-5381.1996.tb15302.x] [PMID: 8730735]
[11]
Pan GY, Huang ZJ, Wang GJ, et al. The antihyperglycaemic activity of berberine arises from a decrease of glucose absorption. Planta Med 2003; 69(7): 632-6.
[http://dx.doi.org/10.1055/s-2003-41121] [PMID: 12898419]
[12]
Manoharan S, Sindhu G, Nirmal MR, Vetrichelvi V, Balakrishnan S. Protective effect of berberine on expression pattern of apoptotic, cell proliferative, inflammatory and angiogenic markers during 7,12-dimethylbenz(a)anthracene induced hamster buccal pouch carcinogenesis. Pak J Biol Sci 2011; 14(20): 918-32.
[http://dx.doi.org/10.3923/pjbs.2011.918.932] [PMID: 22514893]
[13]
Yang Y, Wang Q, Xie M, et al. Berberine exerts an anti-inflammatory role in ocular Behcet’s disease. Mol Med Rep 2017; 15(1): 97-102.
[http://dx.doi.org/10.3892/mmr.2016.5980] [PMID: 27922688]
[14]
Huang SX, Qiu G, Cheng FR, et al. Berberine Protects Secondary Injury in Mice with Traumatic Brain Injury Through Anti-oxidative and Anti-inflammatory Modulation. Neurochem Res 2018; 43(9): 1814-25.
[http://dx.doi.org/10.1007/s11064-018-2597-5] [PMID: 30027364]
[15]
Ma L, Xiao P, Guo B, Wu J, Liang F, Dong S. Cerebral protective effects of some compounds isolated from traditional Chinese herbs. Zhongguo Zhongyao Zazhi 1999; 24(4): 238-239,256.
[PMID: 12205950]
[16]
Yang MH, Kim J, Khan IA, Walker LA, Khan SI. Nonsteroidal anti-inflammatory drug activated gene-1 (NAG-1) modulators from natural products as anti-cancer agents. Life Sci 2014; 100(2): 75-84.
[http://dx.doi.org/10.1016/j.lfs.2014.01.075] [PMID: 24530873]
[17]
Chen YX, Gao QY, Zou TH, et al. Berberine versus placebo for the prevention of recurrence of colorectal adenoma: a multicentre, double-blinded, randomised controlled study. Lancet Gastroenterol Hepatol 2020; 5(3): 267-75.
[http://dx.doi.org/10.1016/S2468-1253(19)30409-1] [PMID: 31926918]
[18]
Cheng N, Chytil A, Shyr Y, Joly A, Moses HL. Transforming growth factor-beta signaling-deficient fibroblasts enhance hepatocyte growth factor signaling in mammary carcinoma cells to promote scattering and invasion. Mol Cancer Res 2008; 6(10): 1521-33.
[http://dx.doi.org/10.1158/1541-7786.MCR-07-2203] [PMID: 18922968]
[19]
Tak J, Sabarwal A, Shyanti RK, Singh RP. Berberine enhances posttranslational protein stability of p21/cip1 in breast cancer cells viadown-regulation of Akt. Mol Cell Biochem 2019; 458(1-2): 49-59.
[http://dx.doi.org/10.1007/s11010-019-03529-4] [PMID: 30911957]
[20]
Kuo HP, Chuang TC, Yeh MH, et al. Growth suppression of HER2-overexpressing breast cancer cells by berberine viamodulation of the HER2/PI3K/Akt signaling pathway. J Agric Food Chem 2011; 59(15): 8216-24.
[http://dx.doi.org/10.1021/jf2012584] [PMID: 21699261]
[21]
Hu Q, Li L, Zou X, Xu L, Yi P. Berberine Attenuated Proliferation, Invasion and Migration by Targeting the AMPK/HNF4α/WNT5A Pathway in Gastric Carcinoma. Front Pharmacol 2018; 9: 1150.
[http://dx.doi.org/10.3389/fphar.2018.01150] [PMID: 30405404]
[22]
Li F, Dong X, Lin P, Jiang J. Regulation of Akt/FoxO3a/Skp2 Axis Is Critically Involved in Berberine-Induced Cell Cycle Arrest in Hepatocellular Carcinoma Cells. Int J Mol Sci 2018; 19(2): E327.
[http://dx.doi.org/10.3390/ijms19020327] [PMID: 29360760]
[23]
Xu LN, Lu BN, Hu MM, et al. Mechanisms involved in the cytotoxic effects of berberine on human colon cancer HCT-8 cells. Biocell 2012; 36(3): 113-20.
[PMID: 23682426]
[24]
Lin YS, Chiu YC, Tsai YH, et al. Different mechanisms involved in the berberine-induced antiproliferation effects in triple-negative breast cancer cell lines. J Cell Biochem 2019; 120(8): 13531-44.
[http://dx.doi.org/10.1002/jcb.28628] [PMID: 30957305]
[25]
Eo SH, Kim JH, Kim SJ. Induction of G₂/M Arrest by Berberine viaActivation of PI3K/Akt and p38 in Human Chondrosarcoma Cell Line. Oncol Res 2014; 22(3): 147-57.
[http://dx.doi.org/10.3727/096504015X14298122915583] [PMID: 26168133]
[26]
Jiang SX, Qi B, Yao WJ, et al. Berberine displays antitumor activity in esophageal cancer cells in vitro. World J Gastroenterol 2017; 23(14): 2511-8.
[http://dx.doi.org/10.3748/wjg.v23.i14.2511] [PMID: 28465635]
[27]
Kroemer G, Galluzzi L, Vandenabeele P, et al. Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009. Cell Death Differ 2009; 16(1): 3-11.
[http://dx.doi.org/10.1038/cdd.2008.150] [PMID: 18846107]
[28]
Schulze-Osthoff K, Ferrari D, Los M, Wesselborg S, Peter ME. Apoptosis signaling by death receptors. Eur J Biochem 1998; 254(3): 439-59.
[http://dx.doi.org/10.1046/j.1432-1327.1998.2540439.x] [PMID: 9688254]
[29]
Seo YS, Yim MJ, Kim BH, et al. Berberine-induced anticancer activities in FaDu head and neck squamous cell carcinoma cells. Oncol Rep 2015; 34(6): 3025-34.
[http://dx.doi.org/10.3892/or.2015.4312] [PMID: 26503508]
[30]
Zamzami N, Kroemer G. The mitochondrion in apoptosis: how Pandora’s box opens. Nat Rev Mol Cell Biol 2001; 2(1): 67-71.
[http://dx.doi.org/10.1038/35048073] [PMID: 11413468]
[31]
Kirkin V, Joos S, Zörnig M. The role of Bcl-2 family members in tumorigenesis. Biochim Biophys Acta 2004; 1644(2-3): 229-49.
[http://dx.doi.org/10.1016/j.bbamcr.2003.08.009] [PMID: 14996506]
[32]
Belmar J, Fesik SW. Small molecule Mcl-1 inhibitors for the treatment of cancer. Pharmacol Ther 2015; 145: 76-84.
[http://dx.doi.org/10.1016/j.pharmthera.2014.08.003] [PMID: 25172548]
[33]
Strasser A, Harris AW, Bath ML, Cory S. Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2. Nature 1990; 348(6299): 331-3.
[http://dx.doi.org/10.1038/348331a0] [PMID: 2250704]
[34]
Beverly LJ, Varmus HE. MYC-induced myeloid leukemogenesis is accelerated by all six members of the antiapoptotic BCL family. Oncogene 2009; 28(9): 1274-9.
[http://dx.doi.org/10.1038/onc.2008.466] [PMID: 19137012]
[35]
Zhao Y, Jing Z, Lv J, et al. Berberine activates caspase-9/cytochrome c-mediated apoptosis to suppress triple-negative breast cancer cells in vitro and in vivo. Biomed Pharmacother 2017; 95: 18-24.
[http://dx.doi.org/10.1016/j.biopha.2017.08.045] [PMID: 28826092]
[36]
Fu L, Chen W, Guo W, et al. Berberine Targets AP-2/hTERT, NF-κB/COX-2, HIF-1α/VEGF and Cytochrome-c/Caspase Signaling to Suppress Human Cancer Cell Growth. PLoS One 2013; 8(7): e69240.
[http://dx.doi.org/10.1371/journal.pone.0069240] [PMID: 23869238]
[37]
Wang N, Feng Y, Zhu M, et al. Berberine induces autophagic cell death and mitochondrial apoptosis in liver cancer cells: the cellular mechanism. J Cell Biochem 2010; 111(6): 1426-36.
[http://dx.doi.org/10.1002/jcb.22869] [PMID: 20830746]
[38]
White E. Deconvoluting the context-dependent role for autophagy in cancer. Nat Rev Cancer 2012; 12(6): 401-10.
[http://dx.doi.org/10.1038/nrc3262] [PMID: 22534666]
[39]
Mohammadinejad R, Ahmadi Z, Tavakol S, Ashrafizadeh M. Berberine as a potential autophagy modulator. J Cell Physiol 2019.
[http://dx.doi.org/10.1002/jcp.28325] [PMID: 30770555]
[40]
La X, Zhang L, Li Z, Yang P, Wang Y. Berberine-induced autophagic cell death by elevating GRP78 levels in cancer cells. Oncotarget 2017; 8(13): 20909-24.
[http://dx.doi.org/10.18632/oncotarget.14959] [PMID: 28157699]
[41]
Zhang Q, Wang X, Cao S, et al. Berberine represses human gastric cancer cell growth in vitro and in vivo by inducing cytostatic autophagy viainhibition of MAPK/mTOR/p70S6K and Akt signaling pathways. Biomed Pharmacother 2020; 128: 110245.
[http://dx.doi.org/10.1016/j.biopha.2020.110245] [PMID: 32454290]
[42]
Wang Y, Liu Y, Du X, Ma H, Yao J. Berberine Reverses Doxorubicin Resistance by Inhibiting Autophagy Through the PTEN/Akt/mTOR Signaling Pathway in Breast Cancer. OncoTargets Ther 2020; 13: 1909-19.
[http://dx.doi.org/10.2147/OTT.S241632] [PMID: 32184626]
[43]
Shiwarski DJ, Shao C, Bill A, et al. To “grow” or “go”: TMEM16A expression as a switch between tumor growth and metastasis in SCCHN. Clin Cancer Res 2014; 20(17): 4673-88.
[http://dx.doi.org/10.1158/1078-0432.CCR-14-0363] [PMID: 24919570]
[44]
Tsang CM, Cheung KC, Cheung YC, et al. Berberine suppresses Id-1 expression and inhibits the growth and development of lung metastases in hepatocellular carcinoma. Biochim Biophys Acta 2015; 1852(3): 541-51.
[http://dx.doi.org/10.1016/j.bbadis.2014.12.004] [PMID: 25496992]
[45]
Qian BZ. Inflammation fires up cancer metastasis. Semin Cancer Biol 2017; 47: 170-6.
[http://dx.doi.org/10.1016/j.semcancer.2017.08.006] [PMID: 28838845]
[46]
Wang X, Wang N, Li H, et al. Up-Regulation of PAI-1 and Down-Regulation of uPA Are Involved in Suppression of Invasiveness and Motility of Hepatocellular Carcinoma Cells by a Natural Compound Berberine. Int J Mol Sci 2016; 17(4): 577.
[http://dx.doi.org/10.3390/ijms17040577] [PMID: 27092498]
[47]
Sharma SD, Katiyar SK. Dietary grape seed proanthocyanidins inhibit UVB-induced cyclooxygenase-2 expression and other inflammatory mediators in UVB-exposed skin and skin tumors of SKH-1 hairless mice. Pharm Res 2010; 27(6): 1092-102.
[http://dx.doi.org/10.1007/s11095-010-0050-9] [PMID: 20143255]
[48]
Singh T, Vaid M, Katiyar N, Sharma S, Katiyar SK. Berberine, an isoquinoline alkaloid, inhibits melanoma cancer cell migration by reducing the expressions of cyclooxygenase-2, prostaglandin E₂ and prostaglandin E₂ receptors. Carcinogenesis 2011; 32(1): 86-92.
[http://dx.doi.org/10.1093/carcin/bgq215] [PMID: 20974686]
[49]
Ferrara N, Kerbel RS. Angiogenesis as a therapeutic target. Nature 2005; 438(7070): 967-74.
[http://dx.doi.org/10.1038/nature04483] [PMID: 16355214]
[50]
Ferrara N. Vascular endothelial growth factor as a target for anticancer therapy. Oncologist 2004; 9(Suppl. 1): 2-10.
[http://dx.doi.org/10.1634/theoncologist.9-suppl_1-2] [PMID: 15178810]
[51]
Jie S, Li H, Tian Y, et al. Berberine inhibits angiogenic potential of Hep G2 cell line through VEGF down-regulation in vitro. J Gastroenterol Hepatol 2011; 26(1): 179-85.
[http://dx.doi.org/10.1111/j.1440-1746.2010.06389.x] [PMID: 21175812]
[52]
Hamsa TP, Kuttan G. Antiangiogenic activity of berberine is mediated through the downregulation of hypoxia-inducible factor-1, VEGF, and proinflammatory mediators. Drug Chem Toxicol 2012; 35(1): 57-70.
[http://dx.doi.org/10.3109/01480545.2011.589437] [PMID: 22145808]
[53]
Kim S, Oh SJ, Lee J, et al. Berberine suppresses TPA-induced fibronectin expression through the inhibition of VEGF secretion in breast cancer cells. Cell Physiol Biochem 2013; 32(5): 1541-50.
[http://dx.doi.org/10.1159/000356591] [PMID: 24335179]
[54]
Hardie DG, Scott JW, Pan DA, Hudson ER. Management of cellular energy by the AMP-activated protein kinase system. FEBS Lett 2003; 546(1): 113-20.
[http://dx.doi.org/10.1016/S0014-5793(03)00560-X] [PMID: 12829246]
[55]
Vanhaesebroeck B, Stephens L, Hawkins P. PI3K signalling: the path to discovery and understanding. Nat Rev Mol Cell Biol 2012; 13(3): 195-203.
[http://dx.doi.org/10.1038/nrm3290] [PMID: 22358332]
[56]
Vanhaesebroeck B, Guillermet-Guibert J, Graupera M, Bilanges B. The emerging mechanisms of isoform-specific PI3K signalling. Nat Rev Mol Cell Biol 2010; 11(5): 329-41.
[http://dx.doi.org/10.1038/nrm2882] [PMID: 20379207]
[57]
Alessi DR, James SR, Downes CP, et al. Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha. Curr Biol 1997; 7(4): 261-9.
[http://dx.doi.org/10.1016/S0960-9822(06)00122-9] [PMID: 9094314]
[58]
Sarbassov DD, Guertin DA, Ali SM, Sabatini DM. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 2005; 307(5712): 1098-101.
[http://dx.doi.org/10.1126/science.1106148] [PMID: 15718470]
[59]
Manning BD, Toker A. AKT/PKB Signaling: Navigating the Network. Cell 2017; 169(3): 381-405.
[http://dx.doi.org/10.1016/j.cell.2017.04.001] [PMID: 28431241]
[60]
Hawley SA, Ross FA, Gowans GJ, Tibarewal P, Leslie NR, Hardie DG. Phosphorylation by Akt within the ST loop of AMPK-α1 down-regulates its activation in tumour cells. Biochem J 2014; 459(2): 275-87.
[http://dx.doi.org/10.1042/BJ20131344] [PMID: 24467442]
[61]
Kuznetsov JN, Leclerc GJ, Leclerc GM, Barredo JC. AMPK and Akt determine apoptotic cell death following perturbations of one-carbon metabolism by regulating ER stress in acute lymphoblastic leukemia. Mol Cancer Ther 2011; 10(3): 437-47.
[http://dx.doi.org/10.1158/1535-7163.MCT-10-0777] [PMID: 21262957]
[62]
Tzatsos A, Tsichlis PN. Energy depletion inhibits phosphatidylinositol 3-kinase/Akt signaling and induces apoptosis viaAMP-activated protein kinase-dependent phosphorylation of IRS-1 at Ser-794. J Biol Chem 2007; 282(25): 18069-82.
[http://dx.doi.org/10.1074/jbc.M610101200] [PMID: 17459875]
[63]
Greer EL, Oskoui PR, Banko MR, et al. The energy sensor AMP-activated protein kinase directly regulates the mammalian FOXO3 transcription factor. J Biol Chem 2007; 282(41): 30107-19.
[http://dx.doi.org/10.1074/jbc.M705325200] [PMID: 17711846]
[64]
Bendas G, Borsig L. Cancer cell adhesion and metastasis: selectins, integrins, and the inhibitory potential of heparins. Int J Cell Biol 2012; 2012: 676731.
[http://dx.doi.org/10.1155/2012/676731] [PMID: 22505933]
[65]
Park JJ, Seo SM, Kim EJ, et al. Berberine inhibits human colon cancer cell migration viaAMP-activated protein kinase-mediated downregulation of integrin β1 signaling. Biochem Biophys Res Commun 2012; 426(4): 461-7.
[http://dx.doi.org/10.1016/j.bbrc.2012.08.091] [PMID: 22943849]
[66]
Chen ZZ. Berberine Induced Apoptosis of Human Osteosarcoma Cells by Inhibiting Phosphoinositide 3 Kinase/Protein Kinase B (PI3K/Akt) Signal Pathway Activation. Iran J Public Health 2016; 45(5): 578-85.
[PMID: 27398330]
[67]
Xie J, Xu Y, Huang X, et al. Berberine-induced apoptosis in human breast cancer cells is mediated by reactive oxygen species generation and mitochondrial-related apoptotic pathway. Tumour Biol 2015; 36(2): 1279-88.
[http://dx.doi.org/10.1007/s13277-014-2754-7] [PMID: 25352028]
[68]
Fan XX, Leung EL, Xie Y, et al. Suppression of Lipogenesis viaReactive Oxygen Species-AMPK Signaling for Treating Malignant and Proliferative Diseases. Antioxid Redox Signal 2018; 28(5): 339-57.
[http://dx.doi.org/10.1089/ars.2017.7090] [PMID: 28665143]
[69]
Kim HS, Kim MJ, Kim EJ, Yang Y, Lee MS, Lim JS. Berberine-induced AMPK activation inhibits the metastatic potential of melanoma cells viareduction of ERK activity and COX-2 protein expression. Biochem Pharmacol 2012; 83(3): 385-94.
[http://dx.doi.org/10.1016/j.bcp.2011.11.008] [PMID: 22120676]
[70]
Gao N, Zhang Z, Jiang BH, Shi X. Role of PI3K/AKT/mTOR signaling in the cell cycle progression of human prostate cancer. Biochem Biophys Res Commun 2003; 310(4): 1124-32.
[http://dx.doi.org/10.1016/j.bbrc.2003.09.132] [PMID: 14559232]
[71]
Wang CW, Klionsky DJ. The molecular mechanism of autophagy. Mol Med 2003; 9(3-4): 65-76.
[http://dx.doi.org/10.1007/BF03402040] [PMID: 12865942]
[72]
Zhao Y, Hu X, Liu Y, et al. ROS signaling under metabolic stress: cross-talk between AMPK and AKT pathway. Mol Cancer 2017; 16(1): 79.
[http://dx.doi.org/10.1186/s12943-017-0648-1] [PMID: 28407774]
[73]
Fruman DA, Rommel C. PI3K and cancer: lessons, challenges and opportunities. Nat Rev Drug Discov 2014; 13(2): 140-56.
[http://dx.doi.org/10.1038/nrd4204] [PMID: 24481312]
[74]
Li W, Hua B, Saud SM, et al. Berberine regulates AMP-activated protein kinase signaling pathways and inhibits colon tumorigenesis in mice. Mol Carcinog 2015; 54(10): 1096-109.
[http://dx.doi.org/10.1002/mc.22179] [PMID: 24838344]
[75]
Wang J, Qi Q, Feng Z, et al. Berberine induces autophagy in glioblastoma by targeting the AMPK/mTOR/ULK1-pathway. Oncotarget 2016; 7(41): 66944-58.
[http://dx.doi.org/10.18632/oncotarget.11396] [PMID: 27557493]
[76]
Yi T, Zhuang L, Song G, Zhang B, Li G, Hu T. Akt signaling is associated with the berberine-induced apoptosis of human gastric cancer cells. Nutr Cancer 2015; 67(3): 523-31.
[http://dx.doi.org/10.1080/01635581.2015.1004733] [PMID: 25837881]
[77]
Xue G, Zippelius A, Wicki A, et al. Integrated Akt/PKB signaling in immunomodulation and its potential role in cancer immunotherapy. J Natl Cancer Inst 2015; 107(7): djv171.
[http://dx.doi.org/10.1093/jnci/djv171] [PMID: 26071042]
[78]
Calnan DR, Brunet A. The FoxO code. Oncogene 2008; 27(16): 2276-88.
[http://dx.doi.org/10.1038/onc.2008.21] [PMID: 18391970]
[79]
Koo KH, Kim H, Bae YK, et al. Salinomycin induces cell death viainactivation of Stat3 and downregulation of Skp2. Cell Death Dis 2013; 4(6): e693.
[http://dx.doi.org/10.1038/cddis.2013.223] [PMID: 23807222]
[80]
Shi J, Zhang L, Shen A, et al. Clinical and biological significance of forkhead class box O 3a expression in glioma: mediation of glioma malignancy by transcriptional regulation of p27kip1. J Neurooncol 2010; 98(1): 57-69.
[http://dx.doi.org/10.1007/s11060-009-0045-8] [PMID: 19911116]
[81]
Taniguchi K, Karin M. NF-κB, inflammation, immunity and cancer: coming of age. Nat Rev Immunol 2018; 18(5): 309-24.
[http://dx.doi.org/10.1038/nri.2017.142] [PMID: 29379212]
[82]
Mortezaee K, Najafi M, Farhood B, Ahmadi A, Shabeeb D, Musa AE. NF-κB targeting for overcoming tumor resistance and normal tissues toxicity. J Cell Physiol 2019; 234(10): 17187-204.
[http://dx.doi.org/10.1002/jcp.28504] [PMID: 30912132]
[83]
Goto H, Kariya R, Shimamoto M, et al. Antitumor effect of berberine against primary effusion lymphoma viainhibition of NF-κB pathway. Cancer Sci 2012; 103(4): 775-81.
[http://dx.doi.org/10.1111/j.1349-7006.2012.02212.x] [PMID: 22320346]
[84]
Lee YC, Lin HH, Hsu CH, Wang CJ, Chiang TA, Chen JH. Inhibitory effects of andrographolide on migration and invasion in human non-small cell lung cancer A549 cells viadown-regulation of PI3K/Akt signaling pathway. Eur J Pharmacol 2010; 632(1-3): 23-32.
[http://dx.doi.org/10.1016/j.ejphar.2010.01.009] [PMID: 20097193]
[85]
Kuo HP, Chuang TC, Tsai SC, et al. Berberine, an isoquinoline alkaloid, inhibits the metastatic potential of breast cancer cells viaAkt pathway modulation. J Agric Food Chem 2012; 60(38): 9649-58.
[http://dx.doi.org/10.1021/jf302832n] [PMID: 22950834]
[86]
Karin M. NF-kappaB as a critical link between inflammation and cancer. Cold Spring Harb Perspect Biol 2009; 1(5): a000141.
[http://dx.doi.org/10.1101/cshperspect.a000141] [PMID: 20066113]
[87]
Lee GR, Jang SH, Kim CJ, et al. Capsaicin suppresses the migration of cholangiocarcinoma cells by down-regulating matrix metalloproteinase-9 expression viathe AMPK-NF-κB signaling pathway. Clin Exp Metastasis 2014; 31(8): 897-907.
[http://dx.doi.org/10.1007/s10585-014-9678-x] [PMID: 25217963]
[88]
van der Waart AB, van de Weem NM, Maas F, et al. Inhibition of Akt signaling promotes the generation of superior tumor-reactive T cells for adoptive immunotherapy. Blood 2014; 124(23): 3490-500.
[http://dx.doi.org/10.1182/blood-2014-05-578583] [PMID: 25336630]

Rights & Permissions Print Export Cite as
© 2022 Bentham Science Publishers | Privacy Policy